The Apple Watch Series 10 has been making waves with its sleek design and sleep apnea detection system but there's a crucial feature missing in action blood oxygen tracking Or is it The feature was introduced five years ago and has been a staple on Apple smartwatches since then But following a patent dispute with medical tech company Masimo Apple was ordered to stop selling Apple Watch Series 9 and Ultra 2 smartwatches in the US and now the Apple Watch Series 10 is also affected The feature was introduced five years ago and has been a staple on Apple smartwatches since then

What if Apple's assumption that the blood oxygen sensor doesn't infringe on Masimo's patented wearable technology is wrong What might the company have missed in its development process The ban on blood oxygen tracking has raised questions about the reliability of Apple's smartwatches Does this mean that Apple's smartwatches are not as reliable as they claimed to be Apple's blood oxygen sensors were developed in-house but did they really innovate or did they borrow from someone else's patented tech Has Apple compromised on the quality of its smartwatches to avoid sharing revenue with Masimo What alternatives are available for users who need blood oxygen tracking Should they be forced to switch to a different smartwatch or rely on a separate device

The patent dispute has been ongoing for years with Apple trying to get the ruling overturned But until then it seems that the blood oxygen measurement system on the Apple Watch Series 10 will remain dormant for buyers in the US Will Apple's smartwatches be able to regain their credibility and reliability once the dispute is resolved Only time will tell One thing is certain though the absence of blood oxygen tracking is a critical feature that will leave many users disappointed Will Apple learn from this experience and prioritize innovation over patent disputes in the future

Apple Watch Series 10: A Critical Feature Missing in Action?

Actions